Interstitial Lung Disease

Lung disease that patients with cancer experience from the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki can be treated effectively if detected early and managed promptly, according to study results published in ESMO Open.

Short telomeres were strongly associated with prevalent interstitial lung disease among patients with rheumatoid arthritis, according to cross-sectional study results published in Respiratory Medicine.

Worse cough-specific quality of life appears to be associated with risk for respiratory hospitalization, death and lung transplantation in patients with interstitial lung disease, researchers reported in Chest.

In the phase 2 TRAIL1 trial, treatment with pirfenidone slowed the rate of lung function decline in patients with rheumatoid arthritis-associated interstitial lung disease and demonstrated a similar safety profile to that observed in other trials of the drug.

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

Children’s interstitial lung diseases were associated with high utilization of health care services in European countries and subsequent economic burden on health systems, researchers reported in Thorax.

It is important to consider interstitial lung disease subtypes when applying progressive fibrosing ILD criteria, researchers concluded in an analysis published in European Respiratory Journal.

The incidence of acute exacerbation was nearly one-third in patients with rheumatoid arthritis-associated interstitial lung disease, researchers reported in Chest.

The most frequent cause of death in patients with rheumatoid arthritis-associated interstitial lung disease and also those with idiopathic pulmonary fibrosis is acute exacerbation, researchers reported.

Concomitant medication burden is associated with antifibrotic medication intolerance among patients with idiopathic pulmonary fibrosis, according to research published in Annals of the American Thoracic Society.